亚太地区语音/语音生物标记市场按平台类型、适应症、应用类型、最终用户和国家分類的分析与预测（2025-2035 年）

预计到 2035 年，亚太地区语音/言语生物标记市场规模将达到 11.821 亿美元，高于 2024 年的 2.217 亿美元，在 2025-2035 年预测期内的复合年增长率为 16.5%。

亚太地区正在创建和使用语音/言语生物标记来检测、追踪和预测疾病。作为数位生物标记的分支，这些生物标记利用人类语音中可量化的特征，例如音高、音调、频率、振幅、语速和颤抖。这些特征反映了潜在的生理和病理状况，从而实现持续的健康监测和非侵入性诊断。

亚太地区语音生物标记市场包括硬体辅助诊断设备、人工智慧软体平台以及整合远距远端保健系统，这些系统透过分析语音数据，对神经系统、精神系统、呼吸系统、心血管系统和认知系统疾病进行早期诊断。除了典型的临床应用外，这些技术还应用于国防、健康、职业健康和认知表现监测等领域。

人工智慧和机器学习的发展、远端医疗和远距医疗基础设施的日益普及，以及对快速、可扩展且价格合理的筛检技术（而非传统诊断技术）日益增长的需求，是推动该地区市场扩张的关键因素。政府计画的支持、医疗保健数位化的不断推进以及人们对预防性医疗保健解决方案日益增长的认识，正引领着日本、中国、印度、韩国和澳洲等国家树立起医疗认证的标准。

市场介绍

亚太地区语音/言语生物标记物产业专注于利用人类语音特征作为生物标记物来识别、追踪和预测健康问题，正迅速成为该地区数位健康领域的关键领域。语音生物标记可测量音高、音调、频率、振幅、语速、震颤以及其他指示健康和病理的特征。在医疗保健的可及性和效率仍面临巨大障碍的地区，这些非侵入性生物标记物至关重要，因为它们能够实现远端监控、早期诊断和个人化患者照护。

该市场涵盖硬体辅助诊断工具、机器学习演算法和人工智慧软体解决方案。由于澳洲、中国、韩国、印度和日本等国家对心理健康监测的重视程度不断提高、人们对神经系统疾病和慢性疾病的认识不断加深以及医疗保健数位化不断提高，这些国家的采用率正在不断提高。语音生物标记与远端医疗平台的整合正在加速持续健康监测和病患参与，尤其是在医疗服务不足和偏远地区。

研究机构、科技公司、数位医疗新兴企业和医疗保健提供者是支持该地区创新和成长的关键市场参与企业。鼓励使用数位医疗的政府计画和监管变化也在推动该行业的扩张。由于对非侵入性诊断、可扩展人工智慧解决方案和技术应用的需求不断增长，亚太地区的语音生物标记市场预计将实现显着增长。

市场区隔

细分一：依平台类型

• 云端基础
• 基于网路

细分2：依适应症类型

• 神经系统疾病
• 精神疾病
• 呼吸系统疾病
• 心血管疾病
• 其他的

细分 3：按应用程式类型

• 诊断
• 监控
• 临床研究
• 其他的

细分 4：按最终用户

• 医院
• CRO
• 研究所

细分5：按地区

• 亚太地区
  • 日本
  • 印度
  • 中国
  • 澳洲
  • 韩国
  • 其他的

亚太地区语音/言语生物标记市场趋势、驱动因素与挑战

市场趋势

• 人工智慧与机器学习的融合：越来越多地采用人工智慧/机器学习演算法来分析声音特征，从而提高预测准确性并早期发现疾病。
• 远端医疗和远端监控：远端医疗平台和语音生物标记的整合度不断提高，以实现持续的远端患者监护。
• 超越临床应用：将应用扩展到健康、认知功能追踪、职业健康和防御领域。
• 多语言解决方案的兴起：发展可适应亚太地区多种语言和地区口音的语音生物标记解决方案。
• 与穿戴式装置的整合：语音分析越来越多地与穿戴式装置集成，以实现即时健康追踪。

关键市场驱动因素

• 医疗保健数位化不断提高：政府对数位医疗基础设施的措施和投资正在推动其应用。
• 对非侵入性诊断的需求：与传统诊断方法相比，人们越来越偏好使用低成本、非侵入性的工具。
• 慢性疾病和神经系统疾病的盛行率不断上升：重点关注精神病、认知疾病、心血管疾病、呼吸系统疾病和神经系统疾病的早期发现。
• 扩充性且经济高效：语音生物标记解决方案可提供适合大量人群的快速、可扩展的筛检。
• 不断增强的意识和健康意识：患者对个人化预防医学的认识和兴趣日益增强。

市场挑战

• 监管和合规障碍：应对亚太国家不同的医疗保健法规。
• 资料隐私和安全问题：确保敏感语音健康资料的安全储存和合乎道德的使用。
• 语言和口音多样性：开发跨多种语言和地区方言的精确演算法。
• 有限的临床检验：在被医疗保健专业人员接受之前，需要进行更大规模的临床研究。
• 基础设施差距：农村和服务欠缺地区取得数位医疗技术的机会不均衡。

产品/创新策略：本报告深入探讨了语音/语音生物标记的最新技术进步，使公司能够推动创新并开发符合市场需求的尖端产品。

成长/行销策略：透过提供全面的市场分析和识别关键的成长机会，公司能够获得制定有针对性的行销策略和有效扩大其市场占有率的知识。

竞争策略：报告包括全面的竞争格局分析，使公司能够了解其竞争对手在语音/声音生物标誌物市场中的优势和劣势，并制定有效的策略以在市场上获得竞争优势。

监管与合规策略：提供有关声音/声音生物标誌物的法律规范、核准和行业指南的最新信息，使公司能够保持合规并加速新声音/声音生物标誌物的市场进入。

投资和业务扩大策略：透过分析市场趋势、资金筹措模式和合作机会，我们帮助公司做出明智的投资决策并确定业务成长的潜在併购机会。

目录

执行摘要

第一章 语音生物标记市场：产业展望

• 产业展望
  • 市场概况与生态系统
  • 竞争力评估
  • 机会评估
  • 资金筹措分析
• 市场动态
  • 趋势、驱动因素、挑战和机会：评估当前和未来的影响
• 趋势
  • 将AI/ML整合到语音生物标记技术中
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场挑战

第二章 区域

• 亚太地区
  • 区域概况
  • 市场成长动力
  • 成长抑制因素
  • 市场规模及预测
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 其他的

第三章：竞争格局与公司概况

• 公司简介
  • PST Inc.

第四章调查方法

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Voice/Vocal Biomarker Market

The Asia-Pacific voice/vocal biomarker market is projected to reach $1,182.1 million by 2035 from $221.7 million in 2024, growing at a CAGR of 16.5% during the forecast period 2025-2035. Vocal or voice biomarkers are being created and used in the Asia-Pacific (APAC) area to detect, track, and forecast medical diseases. As a subgroup of digital biomarkers, these biomarkers use quantifiable aspects of human voice, including pitch, tone, frequency, amplitude, speech pace, and tremor. These characteristics allow for ongoing health monitoring and non-invasive diagnoses by reflecting underlying physiological and pathological conditions.

In order to diagnose neurological, mental health, respiratory, cardiovascular, and cognitive diseases early on, the APAC voice biomarker market comprises hardware-assisted diagnostic instruments, AI-powered software platforms, and telehealth-integrated systems that analyze voice data. These technologies are also being used in the fields of defense, wellness, occupational health, and cognitive performance monitoring in addition to typical clinical applications.

Developments in AI and machine learning, the growing use of telemedicine and remote healthcare infrastructure, and the growing need for quick, scalable, and affordable screening technologies as opposed to traditional diagnostic techniques are the main factors propelling the region's market expansion. With the help of government programs, increasing healthcare digitization, and increased awareness of preventive health solutions, nations like Japan, China, India, South Korea, and Australia are setting the standard for acceptance.

Market Introduction

Focusing on employing human speech characteristics as biological markers to identify, track, and forecast health issues, the Asia-Pacific (APAC) voice and vocal biomarker industry is quickly becoming a significant sector of the region's digital health environment. Pitch, tone, frequency, amplitude, speech pace, tremor, and other characteristics that represent healthy or pathological states are measured by vocal biomarkers. In the APAC area, where healthcare access and efficiency continue to be major obstacles, these non-invasive biomarkers are extremely essential since they allow for remote monitoring, early diagnosis, and individualized patient care.

The market includes hardware-assisted diagnostic tools, machine learning algorithms, and software solutions driven by AI. Adoption is being driven by nations like Australia, China, South Korea, India, Japan, and others because of growing emphasis on mental health monitoring, expanding awareness of neurological disorders and chronic diseases, and more healthcare digitization. Voice biomarker integration with telemedicine platforms is speeding up ongoing health monitoring and patient involvement, especially in underserved or remote places.

Research institutes, technology firms, digital health startups, and healthcare providers are important market participants that support innovation and regional growth. Government programs and regulatory changes that encourage the use of digital healthcare are also driving industry expansion. The market for speech biomarkers in Asia-Pacific is expected to develop significantly due to rising need for non-invasive diagnostics, scalable AI solutions, and technological adoption.

Market Segmentation:

Segmentation 1: By Platform Type

• Cloud-based
• Web-based

Segmentation 2: By Indication Type

• Neurological Disorder
• Mental Health Disorder
• Respiratory Diseases
• Cardiovascular Disease
• Others

Segmentation 3: By Application Type

• Diagnostics
• Monitoring
• Clinical Research
• Others

Segmentation 4: By End User

• Hospitals
• CROs
• Research Institutions

Segmentation 5: By Region

• Asia-Pacific
  • Japan
  • India
  • China
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

APAC Voice/Vocal Biomarker Market Trends, Drivers & Challenges

Market Trends

• AI and Machine Learning Integration: Growing adoption of AI/ML algorithms for analyzing vocal features, improving predictive accuracy and early disease detection.
• Telehealth and Remote Monitoring: Increased integration of voice biomarkers with telemedicine platforms for continuous, remote patient monitoring.
• Expansion Beyond Clinical Use: Applications are expanding to wellness, cognitive performance tracking, occupational health, and defense sectors.
• Rise of Multilingual Solutions: Development of voice biomarker solutions capable of handling multiple languages and regional accents across APAC.
• Collaboration with Wearables: Voice analysis increasingly integrated with wearable devices for real-time health tracking.

Key Market Drivers

• Rising Healthcare Digitization: Government initiatives and investments in digital health infrastructure driving adoption.
• Non-Invasive Diagnostics Demand: Growing preference for low-cost, non-invasive tools over traditional diagnostic methods.
• Increasing Prevalence of Chronic & Neurological Disorders: Focus on early detection of mental health, cognitive, cardiovascular, respiratory, and neurological conditions.
• Scalability & Cost-Effectiveness: Voice biomarker solutions offer rapid, scalable screening suitable for large populations.
• Growing Awareness & Health Consciousness: Rising patient awareness and interest in personalized, preventive healthcare.

Market Challenges

• Regulatory & Compliance Hurdles: Navigating diverse healthcare regulations across APAC countries.
• Data Privacy & Security Concerns: Ensuring secure storage and ethical use of sensitive voice health data.
• Language & Accent Diversity: Developing accurate algorithms for multiple languages and regional dialects.
• Limited Clinical Validation: Need for more large-scale clinical studies to gain acceptance among healthcare professionals.
• Infrastructure Gaps: Uneven access to digital health technologies in rural and underserved regions.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in voice/vocal biomarker, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Voice/Vocal Biomarker and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Voice/Vocal Biomarker, ensuring organizations stay compliant and accelerate market entry for new voice/vocal biomarker

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Table of Contents

Executive Summary

Scope and Definition

1 Voice/Vocal Biomarker Market: Industry Outlook

• 1.1 Industry Outlook
  • 1.1.1 Market Overview and Ecosystem
    • 1.1.1.1 Future Direction and Emerging Technology
  • 1.1.2 Competitive Assessment
    • 1.1.2.1 Go-to-Market Strategy
    • 1.1.2.2 Competitive Landscape
      • 1.1.2.2.1 Business Strategies
  • 1.1.3 Opportunity Assessment
    • 1.1.3.1 Strategic Opportunities of Stakeholders in Voice/Vocal Biomarker Market
    • 1.1.3.2 Market Opportunity and Demand Analysis
  • 1.1.4 Funding Analysis
• 1.2 Market Dynamics
  • 1.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
• 1.3 Trends
  • 1.3.1 Integration of AI/ML into Vocal Biomarker Technologies
  • 1.3.2 Market Drivers
    • 1.3.2.1 Rising Application of Vocal Biomarkers as Novel Diagnostic and Monitoring Aid
    • 1.3.2.2 Increasing Demand for Remote and Non-Invasive Health Monitoring
    • 1.3.2.3 Adoption of Vocal Biomarkers in Health and Wellness Apps
  • 1.3.3 Market Restraints
    • 1.3.3.1 Regulatory Challenges and Unclear Guidelines
      • 1.3.3.1.1 Regulatory Approval for AI/ML-based Vocal Biomarker Applications
      • 1.3.3.1.2 Need for Clinical Validation
    • 1.3.3.2 Integration of Vocal Biomarker Technologies in Healthcare Systems and Associated Complexities
      • 1.3.3.2.1 Integration with EHR
      • 1.3.3.2.2 Integration with Telehealth Platforms
      • 1.3.3.2.3 Integration with Wearables and Smart Devices
  • 1.3.4 Market Opportunities
    • 1.3.4.1 Early Disease Detection and Prevention using Vocal Biomarkers
    • 1.3.4.2 Increasing Number of Clinical Trials and Research on Vocal Biomarker
  • 1.3.5 Market Challenges
    • 1.3.5.1 Technology Limitations and Accuracy Issues
    • 1.3.5.2 Lack of Standardized Regulations on Vocal Biomarker

2 Region

• 2.1 Asia-Pacific
  • 2.1.1 Regional Overview
  • 2.1.2 Driving Factors for Market Growth
  • 2.1.3 Factors Challenging the Market
  • 2.1.4 Market Sizing and Forecast
    • 2.1.4.1 Asia-Pacific Voice/Vocal Biomarkers Market, by Platform Type
    • 2.1.4.2 Asia-Pacific Voice/Vocal Biomarkers Market, by Application
    • 2.1.4.3 Asia-Pacific Voice/Vocal Biomarkers Market, by Indication
    • 2.1.4.4 Asia-Pacific Voice/Vocal Biomarkers Market, by End User
    • 2.1.4.5 Asia-Pacific Voice/Vocal Biomarkers Market, by Country
  • 2.1.5 China
    • 2.1.5.1 Country Overview
      • 2.1.5.1.1 Market Sizing and Forecast
  • 2.1.6 Japan
    • 2.1.6.1 Country Overview
      • 2.1.6.1.1 Market Sizing and Forecast
  • 2.1.7 India
    • 2.1.7.1 Country Overview
      • 2.1.7.1.1 Market Sizing and Forecast
  • 2.1.8 Australia
    • 2.1.8.1 Country Overview
      • 2.1.8.1.1 Market Sizing and Forecast
  • 2.1.9 South Korea
    • 2.1.9.1 Country Overview
      • 2.1.9.1.1 Market Sizing and Forecast
  • 2.1.10 Rest-of-the- Asia-Pacific
    • 2.1.10.1 Country Overview
      • 2.1.10.1.1 Market Sizing and Forecast

3 Competitive Landscape and Company Profiles

• 3.1 Company Profiles
  • 3.1.1 PST Inc.
    • 3.1.1.1 Overview

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Inclusion and Exclusion
  • 4.1.4 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Voice/Vocal Biomarker Market (by Scenario), $Million, 2024, 2028, and 2035
• Figure 2: Asia-Pacific Voice/Vocal Biomarker Market, 2024-2035
• Figure 3: Asia-Pacific Voice/Vocal Biomarker Market Snapshot
• Figure 4: Voice/Vocal Biomarker Market, $Million, 2024 and 2035
• Figure 5: Asia-Pacific Voice/Vocal Biomarker Market (by Platform Type), $Million, 2024, 2028, and 2035
• Figure 6: Asia-Pacific Voice/Vocal Biomarker Market (by Application Type), $Million, 2024, 2028, and 2035
• Figure 7: Asia-Pacific Voice/Vocal Biomarker Market (by Indication Type), $Million, 2024, 2028, and 2035
• Figure 8: Asia-Pacific Voice/Vocal Biomarker Market (by End User), $Million, 2024, 2028, and 2035
• Figure 9: Go-to-Market Strategy of Major Players
• Figure 10: Go-to-Market Strategy of Major Players
• Figure 11: Go-to-Market Strategy of Major Players
• Figure 12: Companies Offering AI-based Vocal Biomarkers for Early Disease Detection
• Figure 13: Asia Pacific Voice/Vocal Biomarkers Market, $Million, 2024-2035
• Figure 14: China Voice/Vocal BIomarkers Market, $Million, 2024-2035
• Figure 15: Japan Voice/Vocal BIomarkers Market, $Million, 2024-2035
• Figure 16: India Voice/Vocal BIomarkers Market, $Million, 2024-2035
• Figure 17: Australia Voice/Vocal BIomarkers Market, $Million, 2024-2035
• Figure 18: South-Korea Voice/Vocal BIomarkers Market, $Million, 2024-2035
• Figure 19: Rest-of-the Asia-Pacific Voice/Vocal BIomarkers Market, $Million, 2024-2035
• Figure 20: Inclusion and Exclusion Criteria for Voice/Vocal Biomarker Market
• Figure 21: Data Triangulation
• Figure 22: Top-Down and Bottom-Up Approach
• Figure 23: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Recent Funding in Voice/Vocal Biomarker Market
• Table 3: Use of AI/ML Technology by Companies
• Table 4: Key Market Players and their Major Contributions
• Table 5: Few Clinical Trials Related to Voice Biomarker
• Table 6: Voice/Vocal Biomarkers Market (by Region), $Million, 2024-2035
• Table 7: Asia-Pacific Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
• Table 8: Asia-Pacific Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
• Table 9: Asia-Pacific Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
• Table 10: Asia-Pacific Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
• Table 11: Asia-Pacific Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035